Abstract
Introduction
Microdamage accumulation due to fatigue loading may lead to fracture. In addition, several studies using animal models have suggested in recent years that bisphosphonates might increase microdamage accumulation.
Methods
We have reviewed the literature after a PubMed search, to examine the techniques to look for microcracks, the relationship between microdamage and bone strength, and the influence of anti-osteoporosis agents.
Results
Currently, the search for microcracks relies on bulk staining of bone samples, which are then examined on optic microscopy and fluorescence or confocal microscopy. The accumulation of microdamage is associated with fatigue loading and is likely to trigger targeted bone remodeling, especially in cortical bone. Several studies examining beagle dogs receiving bisphosphonates have shown a dose-dependent accumulation of microdamage in bone, with conflicting results regarding the consequences on bone mechanical properties. In living humans, obtaining data is limited to the iliac crest bone. The potential association between long-term bisphosphonate use and microcrack accumulation at the iliac crest bone has not been established unequivocally.
Conclusions
Bone microdamage is critical in the understanding of bone quality. Assessment of microdamage is technically difficult, especially in humans. The clinical impact of microdamage potentially induced by bone drugs has not been established in humans.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00198-009-0899-9/MediaObjects/198_2009_899_Fig1_HTML.gif)
Similar content being viewed by others
References
Krajcinovic D (1984) Continuum damage mechanics. Appl Mech Rev 37:1–5
Mori S, Burr DB (1996) Increased intracortical remodeling following fatigue damage. Bone 14:103–109
Burr DB, Turner CH, Naick P, Forwood MR, Ambrosius W, Hasan MS, Pidaparti R (1998) Does microdamage accumulation affect the mechanical properties of bone? J Biomech 31:337–345
Frost HM (1960) Presence of microscopic cracks in vivo in bone. H Ford Hosp Med Bull 8:27–35
Burr DB, Martin DB, Schaffler MB, Radin EL (1985) Bone remodeling in response to in vivo fatigue microdamage. J Biomech 18:189–200
Mori S, Burr DB (1993) Increased intracortical remodeling following fatigue damage. Bone 14:103–109
Bentolila V, Boyce TM, Fyhrie DP et al (1998) Intracortical remodeling in adult rat long bones after fatigue loading. Bone 23:275–281
Burr DB (2002) Targeted and non targeted remodeling. Bone 30:2–4
Parfitt AM (2002) Targeted and non targeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone 30:5–7
Mashiba T, Hirano T, Turner CH, Forwood M, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15:613–620
Mashiba T, Turner CH, Hirano T, Forwood M, Johnston CC, Burr DB (2001) Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biochemical properties in clinically relevant skeletal sites in beagles. Bone 28:524–531
Komatsubara S, Mori S, Mashiba T, Ito M, Li J, Kaji Y, Akiyama T, Miyamoto K, Cao Y, Kawanashi J, Norimatsu H (2003) Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra. J Bone Miner Res 18:512–520
Forwood MR, Burr DB, Takano Y, Eastman DF, Smith PN, Schwardt JD (1995) Risedronate treatment does not increase microdamage in the canine femoral neck. Bone 16:643–650
Allen MR, Iwata K, Phipps R, Burr DB (2006) Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Bone 39:872–879
Forwood MR, Parker AW (1989) Microdamage in response to repetitive torsional loading in the rat tibia. Calcif Tissue Int 45:47–53
Allen MR, Burr DB (2008) Changes in vertebral strength density and energy absorption density relationships following bisphosphonate treatment in beagle dogs. Osteoporos Int 19:95–99
Burr DB, Stafford T (1990) Validity of the bulk-staining technique to separate artifactual from in vivo bone microdamage. Clin Orthop Rel Res 260:305–308
Burr DB, Hooser M (1995) Alterations to the en bloc basic fuchsin staining protocol for the demonstration of microdamage produced in vivo. Bone 17:431–433
Lee TC, Myers ER, Hayes WC (1998) Florescence-aided detection of microdamage in compact bone. J Anat 193:179–184
Huja SS, Hasan MS, Pidaparti R, Turner CH, Garetto P, Burr DB (1999) Development of a fluorescent light technique for evaluating microdamage in bone subjected to fatigue loading. J Biomech 32:1243–1249
Boyce TM, Fyhrie SP, Glotkowski MC, Radin EL, Schaffler MB (1998) Damage type and strain mode associations inhuman compact bone bending fatigue. J Orthop Res 16:322–329
Fazzalari NL, Forwood MR, Manthey BA, Smith K, Kolesik P (1998) Three-dimensional confocal images of microdamage in cancellous bone. Bone 23:373–378
O’Brien FJ, Taylor D, Dickson GR, Lee TC (2000) Visualization of three dimensional microcracks in compact bone. J Anat 197:413–420
Taylor D, Lee TC (1998) Measuring the shape and size of microcracks in bone. J Biomech 31:1177–1180
Fazzalari NL, Kuliwaba JS, Forwood MR (2002) Cancellous bone microdamage in the proximal femur: influence of age and osteoarthritis on damage morphology and regional distribution. Bone 31:697–702
Lee TC, Mohsin S, Taylor D, Parkesh R, Gunnlaugsson T, O’Brien FJ, Giehl M, Gowin W (2003) Detecting microdamage in bone. J Anat 203:161–172
Zarrinkalam KH, Kuliwaba JS, Martin RB, Wallwork MAB, Fazzalari NL (2005) New insights into the propagation of fatigue damage in cortical bone using confocal microscopy and chelating fluorochromes. Eur J Morphol 42:81–90
Mori S, Harruff R, Ambrosius W, Burr DB (1997) Trabecular bone volume and microdamage accumulation in the femoral heads of women with and without femoral neck fractures. Bone 21:521–526
Schaffler MB, Choi K, Milgrom C (1995) Aging and matrix microdamage accumulation in human compact bone. Bone 17:521–525
Wenzel TE, Schaffler MB, Fyhrie DP (1996) In vivo trabecular microcracks in human vertebral bone. Bone 19:89–95
Arlot M, Burt-Pichat B, Roux JP, Vashishth D, Bouxsein M, Delmas PD (2008) Microarchitecture influences microdamage accumulation in human vertebral trabecular bone. J Bone Miner Res 23:1613–1618
Hasewaga K, Turner CH, Chen J, Burr DB (1995) Effect of disc lesion on microdamage accumulation in lumbar vertebrae under cyclic compression loading. Clin Orthop Rel Res 311:190–198
Sornay-Rendu E, Allard C, Munoz F, Duboeuf F, Delmas PD (2006) Disc space narrowing as a new risk factor for vertebral fracture: the OFELY study. Arthritis Rheum 54:1262–1269
Twomey LT, Taylor JR (1987) Age changes in lumbar vertebrae and intervertebral discs. Clin Orthop Rel Res 224:97–104
Chapurlat RD, Arlot M, Burt-Pichat B, Chavassieux P, Roux JP, Portero-Muzy N, Delmas PD (2007) Microcrack frequency and bone remodelling in postmenopausal osteoporotic women: a bone biopsy study. J Bone Miner Res 22:1502–1509
Stepan JJ, Burr DB, Pavo I, Sipos A, Michalska D, Li J, Fahrleitner-Pammer A, Petto H, Westmore M, Michalsky D, Sato M, Dobnig H (2007) Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women. Bone 41:378–385
Diab T, Condon KW, Burr DB, Vashishth D (2006) Age-related change in the damage morphology of human cortical bone and its role in bone fragility. Bone 38:427–431
Waldorff EI, Goldstein SA, McCreadie BR (2007) Age-dependent microdamage removal following mechanically induced microdamage in trabecular bone in vivo. Bone 40:425–432
Nagaraja S, Lin ASP, Guldberg RE (2007) Age-related changes in trabecular bone microdamage initiation. Bone 40:973–980
Vashishth D, Verborgt O, Divine G, Schaffler MB, Eyhrie DP (2000) Decline in osteocyte lacunar density in human cortical bone is associated with accumulation of microcracks with age. Bone 26:375–380
Schaffler MB, Radin EL, Burr DB (1989) Mechanical and morphological effects of strain rate on fatigue of compact bone. Bone 10:207–214
Pattin CA, Caler WE, Carter DR (1996) Cyclic mechanical property degradation during fatigue loading of cortical bone. J Biomech 29:69–79
Schaffler MB, Radin EL, Burr DB (1990) Long-term fatigue behavior of compact bone at low strain magnitude and rate. Bone 11:321–326
Zioupos P, Currey JD (1994) The extent of microcracking and the morphology of microcracks in damaged bone. J Mat Sci 29:978–986
Pidaparti RM, Wang QY, Burr DB (2001) Modeling fatigue damage evolution in bone. Biomed Mater Eng 11:69–78
Currey J, Brear K, Zioupos P (1996) The effects of ageing and changes in mineral content in degrading the toughness of human femora. J Biomech 29:257–260
Chamay A (1970) Mechanical and morphological aspects of experimental overload and fatigue in bone. J Biomech 3:263–270
Currey JD, Brear K (1974) Tensile yield in bone. Calcif Tissue Res 15:173–179
Reilly GC, Currey JD (1999) The development of microcracking and failure in bone depends on the loading mode to which it is adapted. J Exp Biol 202:543–552
Tschantz P, Rutishauser E (1967) La surcharge mécanique de l'os vivant. Ann Anat Path 12:223–248
Ebacher V, Tang C, McKay H, Oxland TR, Guy P, Wang R (2007) Strain distribution and cracking behavior of human bone during bending. Bone 40:1265–1275
Vashishth D, Behiri JC, Bonfield W (1997) Crack growth resistance in cortical bone: concept of microcrack toughening. J Biomech 30:763–769
Vashishth D, Tanner KE, Bonfield W (2000) Contribution, development and morphology of microcracking in cortical bone during crack propagation. J Biomech 33:1168–1174
Diab T, Vashishth D (2005) Effects of damage morphology on cortical bone fragility. Bone 37:96–102
Mohsin S, O’Brien FJ, Lee TC (2006) Osteonal crack barriers in ovine compact bone. J Anat 208:81–89
Diab T, Vashishth D (2007) Morphology, localization and accumulation of in vivo microdamage in human cortical bone. Bone 40:612–618
Wang X, Zauel RR, Rao SD, Fyhrie DP (2008) Cancellous bone lamellae strongly affect microcrack propagation and apparent mechanical properties: separation of patients with osteoporotic fracture from normal controls using a 2D nonlinear finite element method (biomechanical stereology). Bone 42:1184–1192
Skerry TM, Bitensky L, Chayen J, Lanyon LE (1989) Early strain-related changes in enzyme activity in osteocytes following bone loading in vivo. J Bone Miner Res 4:783–788
Muir P, Sample SJ, Barrett JG, McCarthy J, Vanderby R Jr, Markerl MD, Prokuski LJ, Kalscheur VL (2007) Effect of fatigue loading and associated matrix microdamage on bone blood flow and interstitial fluid flow. Bone 40:948–956
Verborgt O, Gibson GJ, Schaffler MB (2000) Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res 15:60–67
Noble BS, Peet N, Stevens HY, Brabbs A, Mosley JR, Reilly GC, Reeve J, Skerry TM, Lanyon LE (2003) Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone. Am J Physiol Cell Physiol 284:C934–C943
Martin RB (2002) Is all cortical bone remodeling initiated by microdamage? Bone 30:8–13
Flora L, Hassing GS, Parfitt AM, Villaneuva AR (1980) Comparative skeletal effects of two diphosphonates in dogs. Met Bone Dis 2:S389–S407
Boyce BF, Smith L, Fogelman I, Johnston E, Ralston S, Boyle IT (1984) Focal osteomalacia due to low-dose diphosphonate therapy in Paget’s disease. Lancet 1(8381):821–824
Mashiba T, Turner CH, Hirano T, Forwood M, Jacob DS, Johnston CC, Burr DB (2001) Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle dog before occurrence of spontaneous fractures. Bone 29:271–278
Li J, Mashiba T, Burr DB (2001) Bisphosphonates treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage. Calcif Tissue Int 69:281–286
Allen MR, Reinwald S, Burr DB (2008) Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment. Calcif Tissue Int 82:354–360
Allen MR, Burr DB (2007) Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment. J Bone Miner Res 22:1759–1765
Nyman JS, Yeh OC, Hazelwood SJ, Martin RB (2004) A theoretical analysis of long-term bisphosphonate effects on trabecular bone volume and microdamage. Bone 35:296–305
Li J, Sato M, Jerome C, Turner CH, Fan Z, Burr DB (2005) Microdamage accumulation in the monkey vertebra does not occur when bone turnover is suppressed by 50% or less with estrogen or raloxifene. J Bone Miner Metab 23S:48–54
Allen MR, Iwata K, Sato M, Burr DB (2006) Raloxifene enhances vertebral mechanical properties independent of bone density. Bone 39:1130–1135
Black DM, Cummings SR, Karpf DB et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535–1541
Ensrud KE, Black DM, Palermo L et al (1997) Treatment with alendronate prevents fractures in women at highest risk. Arch Intern Med 157:2617–2624
Cummings SR, Black DM, Thompson DE et al (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. JAMA 280:2077–2082
Odvina CV, Zerwekh JE, Rao S, Maalouf N, Gottshalk FA, Pak CYC (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90:1294–1301
Lenart BA, Lane J (2008) Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 358:1304–1305
Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG (2008) Low energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 22:346–350
Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT et al (2007) Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg (Br) 89:349–353
Kwek EB, Kwek EB, Goh SK, Koh JS, Png MA, Howe TS (2008) An emerging pattern of subtrochanteric stress fractures: a long term complication of alendronate therapy? Injury 39:224–231
Lenart BA, Leviaser AS, Lyman S, Chang CC, Edobor-Osula F, Steele B, van Der Meulen MC, Lorich DG, Lane JM. (2008) Association of low-energy femoral fractures with prolonged bisphosphonate use: a case-control study. Osteoporos Int (in press), online
Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC, Libermann IA (2004) Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 90:1189–1199
Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR (2006) Effects of continuing or stopping alendronate after 5 years of treatment the fracture intervention trial long-term extension (FLEX): a randomized trial. JAMA 296:2927–2938
Chapurlat RD, Arlot M, Delmas PD (2008) Low bone turnover and microdamage? How and where to assess it ? J Bone Miner Res 23:1152–1153
Thurner PJ, Wyss P, Voide R, Stauber M, Stampanoni M, Sennhauser U, Muller R (2006) Time-lapsed investigation of three-dimensional failure and damage accumulation in trabecular bone using synchrotron light. Bone 39:289–299
Larrue A, Rattner A, Laroche N, Vico L, Peyrin F (2007) Feasibility of microcrack detection in human trabecular bone images from 3D synchrotron microtomography. Conf Proc IEEE Eng Med Biol Soc 2007:3918–3921
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chapurlat, R.D., Delmas, P.D. Bone microdamage: a clinical perspective. Osteoporos Int 20, 1299–1308 (2009). https://doi.org/10.1007/s00198-009-0899-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-009-0899-9